198 related articles for article (PubMed ID: 2459332)
21. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases.
Amin MB; Paner GP; Alvarado-Cabrero I; Young AN; Stricker HJ; Lyles RH; Moch H
Am J Surg Pathol; 2008 Dec; 32(12):1822-34. PubMed ID: 18813125
[TBL] [Abstract][Full Text] [Related]
22. Chromophobe renal cell carcinoma. Pathologic, ultrastructural, immunohistochemical, cytofluorometric and cytogenetic findings.
Morell-Quadreny L; Gregori-Romero M; Llombart-Bosch A
Pathol Res Pract; 1996 Dec; 192(12):1275-81; discussion 1282. PubMed ID: 9182300
[TBL] [Abstract][Full Text] [Related]
23. Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma.
Geramizadeh B; Ravanshad M; Rahsaz M
Indian J Pathol Microbiol; 2008; 51(2):167-71. PubMed ID: 18603673
[TBL] [Abstract][Full Text] [Related]
24. Chromophobe renal cell carcinoma: a report of two cases.
Fukushima T; Nagashima Y; Nakatani Y; Nakamura N; Fukasawa K; Satomi Y; Yu K; Miyagi Y; Aoki I; Misugi K
Pathol Int; 1994 May; 44(5):401-6. PubMed ID: 7519106
[TBL] [Abstract][Full Text] [Related]
25. [Chromophobe renal cell carcinoma: a clinicopathological study of 16 cases].
Nakaigawa N; Yao M; Kondo K; Kishida T; Noguchi K; Kubota Y; Nagashima Y; Kawano N; Inayama Y; Nozawa A
Hinyokika Kiyo; 2006 Jan; 52(1):1-6. PubMed ID: 16479980
[TBL] [Abstract][Full Text] [Related]
26. Chromophobe renal cell carcinoma and 'capsulomas' with acquired cystic disease of the kidney in a long-term hemodialysis patient.
Nishihara K; Shomori K; Nagashima Y; Kuroda N; Nagamatsu H; Ito H
Int J Urol; 2008 Jun; 15(6):543-5. PubMed ID: 18489645
[TBL] [Abstract][Full Text] [Related]
27. Ultrastructural studies in a series of 18 cases of chromophobe renal cell carcinoma.
Moreno SM; Benítez IA; Martínez González MA
Ultrastruct Pathol; 2005; 29(5):377-87. PubMed ID: 16257864
[TBL] [Abstract][Full Text] [Related]
28. Review of chromophobe renal cell carcinoma with focus on clinical and pathobiological aspects.
Kuroda N; Toi M; Hiroi M; Enzan H
Histol Histopathol; 2003 Jan; 18(1):165-71. PubMed ID: 12507296
[TBL] [Abstract][Full Text] [Related]
29. Progesterone receptor reactivity in renal oncocytoma and chromophobe renal cell carcinoma.
Mai KT; Teo I; Belanger EC; Robertson SJ; Marginean EC; Islam S
Histopathology; 2008 Feb; 52(3):277-82. PubMed ID: 18081814
[TBL] [Abstract][Full Text] [Related]
30. Mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase type II expression in renal cell neoplasms: a tissue microarray and quantitative RT-PCR study.
Yakirevich E; Morris DJ; Tavares R; Meitner PA; Lechpammer M; Noble L; de Rodriguez AF; Gomez-Sanchez CE; Wang LJ; Sabo E; Delellis RA; Resnick MB
Am J Surg Pathol; 2008 Jun; 32(6):874-83. PubMed ID: 18408592
[TBL] [Abstract][Full Text] [Related]
31. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
32. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
33. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
[TBL] [Abstract][Full Text] [Related]
34. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms.
Avery AK; Beckstead J; Renshaw AA; Corless CL
Am J Surg Pathol; 2000 Feb; 24(2):203-10. PubMed ID: 10680888
[TBL] [Abstract][Full Text] [Related]
35. [Adult renal neoplasms in the material of the Pathology Department of the Szeged University].
Németh I; Sükösd F; Béli L; Kiss A; Pajor L; Mikó T; Iványi B
Orv Hetil; 2005 Apr; 146(14):653-8. PubMed ID: 15889540
[TBL] [Abstract][Full Text] [Related]
36. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
[TBL] [Abstract][Full Text] [Related]
37. Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma.
Meyer HA; Tölle A; Jung M; Fritzsche FR; Haendler B; Kristiansen I; Gaspert A; Johannsen M; Jung K; Kristiansen G
Eur Urol; 2009 Mar; 55(3):669-78. PubMed ID: 18450365
[TBL] [Abstract][Full Text] [Related]
38. [A case of chromophobe cell renal carcinoma].
Ashida S; Yamamoto A; Fukumori T; Yuasa K; Terao N; Iwata J
Hinyokika Kiyo; 1997 Nov; 43(11):777-80. PubMed ID: 9436020
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of the enzyme that esterifies retinol, lecithin:retinol acyltransferase, in subtypes of human renal cancer and normal kidney.
Zhan HC; Gudas LJ; Bok D; Rando R; Nanus DM; Tickoo SK
Clin Cancer Res; 2003 Oct; 9(13):4897-905. PubMed ID: 14581364
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of vimentin positivity in formalin-fixed renal cell carcinomas.
Donhuijsen K; Schulz S
Pathol Res Pract; 1989 Mar; 184(3):287-91. PubMed ID: 2748452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
